| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $108,111,599 ) (Continued on the next page) |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01EB034806 | A novel electric current-based treatment system for chronic wound biofilm infections | 000 | 1 | NIH | 7/6/2023 | $377,670 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K0149047 | Geriatric Academic Career Awards | 01 | 1 | HRSA | 6/27/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K0149047 | Geriatric Academic Career Awards | 00 | 1 | HRSA | 4/14/2023 | $86,978 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R00GM138920 | Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | 000 | 3 | NIH | 4/17/2023 | $249,000 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 2301NEILSG | ILSG-2023 | 1 | 1 | ACL | 2/23/2023 | $276,591 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | 2301NEILSG | ILSG-2023 | 0 | 1 | ACL | 11/1/2022 | $71,469 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL163043 | Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury | 002 | 2 | NIH | 8/11/2023 | $496,295 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T5246757 | Public Health Scholarship Program | 03 | 1 | HRSA | 6/15/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T5246757 | Public Health Scholarship Program | 02 | 1 | HRSA | 4/28/2023 | $3,518 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR082148 | Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | 000 | 1 | NIH | 1/15/2023 | $453,017 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK129311 | Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure | 000 | 3 | NIH | 7/4/2023 | $498,034 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R25GM142096 | Encouraging Excellence: Health Science Education in Native American Communities | 000 | 3 | NIH | 2/28/2023 | $270,000 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 000 | 3 | NIH | 12/13/2022 | $301,968 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA233037 | The novel role of microtubule regulators in the DNA damage response | 001 | 3 | NIH | 12/15/2022 | $40,968 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM130447 | Cognitive Neuroscience of Development and Aging (CONDA) Center | 001 | 4 | NIH | 2/15/2023 | $2,279,770 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R35HG010719 | Development of Modular CRISPR Genome Editing Technologies and Tools | 001 | 5 | NIH | 7/17/2023 | $433,796 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K23AG070311 | Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Transplantation (HCT) | 000 | 3 | NIH | 8/31/2023 | $190,188 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F30CA265277 | Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma | 000 | 3 | NIH | 7/12/2023 | $52,694 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS119266 | Discovery and characterization of selective D4R antagonists and their evaluation in preclinical models of PD-LIDs | 000 | 3 | NIH | 5/26/2023 | $559,991 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 000 | 3 | NIH | 1/30/2023 | $452,074 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | K08NS110923 | The Role of Complement in Cerebrospinal Fluid Shunt Infections | 000 | 4 | NIH | 4/14/2023 | $192,132 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA050540 | K channel, NLRP3 inflammasome and Meth exacerbation of HAND | 000 | 5 | NIH | 7/14/2023 | $411,544 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H79SM081769 | BHECN Mental Health Technology Transfer Center | 001 | 5 | SAMHSA | 5/31/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R56DE033004 | Targeting P21 positive senescent cells for alleviating TMJ degeneration | 000 | 1 | NIH | 8/11/2023 | $307,000 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R00AA026877 | Synergy of lipolysis and lipophagy in alcoholic liver disease | 000 | 5 | NIH | 8/25/2023 | $249,000 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA028504 | Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver disease | 000 | 3 | NIH | 5/31/2023 | $339,215 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL155439 | GATA Factor Mechanisms in Erythroid Regeneration | 001 | 3 | NIH | 3/21/2023 | $38,375 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL152160 | Novel Neural Mechanisms underlying Lung-Heart Pathological Crosstalk | 000 | 4 | NIH | 3/20/2023 | $539,046 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK124095 | Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease | 000 | 4 | NIH | 6/5/2023 | $517,434 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AA027695 | Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease | 001 | 5 | NIH | 7/3/2023 | $389,037 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H79SM081769 | BHECN Mental Health Technology Transfer Center | 001 | 5 | SAMHSA | 5/31/2023 | $300,000 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL163288 | HEART Camp Connect: Promoting Adherence to Exercise in Adults with Heart Failure with Preserved Ejection Fraction | 000 | 1 | NIH | 4/15/2023 | $702,652 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL169476 | Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure | 000 | 1 | NIH | 8/28/2023 | $594,440 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F32AA031180 | The role of alcohol-associated microbiota membrane vesicles in mucosal immunity | 001 | 1 | NIH | 4/28/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F32HD106722 | Roles of Hippo signaling and gap junctional communication in follicle development | 001 | 3 | NIH | 8/14/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DE030427 | Greatwall in replication stress/DNA damage responses and oral cancer resistance | 001 | 3 | NIH | 2/9/2023 | $36,337 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL155439 | GATA Factor Mechanisms in Erythroid Regeneration | 000 | 3 | NIH | 12/14/2022 | $345,375 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL146489 | Scar Detection and Treatment with Droplet Activation | 000 | 4 | NIH | 4/1/2023 | $749,202 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DA050545 | Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome | 001 | 5 | NIH | 9/13/2023 | $383,750 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H79SM081769 | BHECN Mental Health Technology Transfer Center | 001 | 5 | SAMHSA | 5/31/2023 | $0 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01ES015869 | Translesion synthesis DNA polymerases and genome instability | 000 | 15 | NIH | 5/3/2023 | $337,896 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P01AI083211 | Staphylococcal Biofilm and Disease | 000 | 15 | NIH | 6/9/2023 | $2,333,452 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U01CA253218 | Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures | 000 | 3 | NIH | 8/8/2023 | $359,942 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AG069609 | The Impact of Environmental Stressors on Chronic Disease Disparities in Women | 000 | 4 | NIH | 4/27/2023 | $597,822 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA259168 | Development of an NTSR1-Targeted Radiotherapeutic for Colorectal Cancer | 000 | 3 | NIH | 3/24/2023 | $321,544 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA250383 | Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer | 001 | 3 | NIH | 8/15/2023 | $238,397 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H7600529 | Ryan White Part C Outpatient EIS Program | 01 | 24 | HRSA | 4/18/2023 | $407,273 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 985805 Nebraska Medical Ctr | Omaha | NE | 68198-5805 | DOUGLAS | USA | H7600529 | Ryan White Part C Outpatient EIS Program | 00 | 24 | HRSA | 12/5/2022 | $292,995 |
| | 2023 | 2023 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01EY029594 | Pathogenesis of Uveitis in Ebola Virus Disease Survivors | 000 | 6 | NIH | 7/18/2023 | $511,328 |
|
